Dow Wilson - Varian Medical President, Chief Executive Officer, Director
CEO
Mr. Dow R. Wilson serves as President, Chief Executive Officer, Director of the Company. Mr. Wilson served as Corporationrationrate Executive Vice President and Chief Operating Officer from October 2011 through September 2012 and as Corporationrationrate Executive Vice President and President, Oncology Systems from August 2005 through September 2011. Mr. Wilson served as Corporationrationrate Vice President and President, Oncology Systems from January 2005 to August 2005. Prior to joining the Company in January 2005, Mr. Wilson was Chief Executive Officer of the HealthcareInformation Technologies business in General Electric, from 2003 to 2005. During the previous 18 years, Mr. Wilson held various management positions within General Electric. Mr. Wilson holds a B.A. degree in English from Brigham Young University and an M.B.A. degree from Dartmouths Amos Tuck School of Business since 2020.
| Age | 61 |
| Tenure | 4 years |
| Phone | 650 493-4000 |
| Web | www.varian.com |
Dow Wilson Latest Insider Activity
Tracking and analyzing the buying and selling activities of Dow Wilson against Varian Medical stock is an integral part of due diligence when investing in Varian Medical. Dow Wilson insider activity provides valuable insight into whether Varian Medical is net buyers or sellers over its current business cycle. Note, Varian Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Varian Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Dow Wilson over a year ago Sale by Dow Wilson of 82500 shares of Varian Medical |
Varian Medical Management Efficiency
The company has Return on Asset of 5.92 % which means that on every $100 spent on assets, it made $5.92 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 13.51 %, implying that it generated $13.51 on every 100 dollars invested. Varian Medical's management efficiency ratios could be used to measure how well Varian Medical manages its routine affairs as well as how well it operates its assets and liabilities.Varian Medical Systems has 350.5 M in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Varian Medical Systems has a current ratio of 1.48, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Varian to invest in growth at high rates of return.
Similar Executives
| Found 4 records | CEO Age | ||
| Julie Schertell | Mativ Holdings | 55 | |
| Mark Nikolich | Braskem SA Class | N/A | |
| Andrew Spodek | Postal Realty Trust | 48 | |
| Roberto Simoes | Braskem SA Class | 67 | |
Management Performance
| Return On Equity | 13.51 | |||
| Return On Asset | 5.92 |
Varian Medical Systems Leadership Team
Elected by the shareholders, the Varian Medical's board of directors comprises two types of representatives: Varian Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Varian. The board's role is to monitor Varian Medical's management team and ensure that shareholders' interests are well served. Varian Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Varian Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey Balser, Independent Director | ||
| R Eckert, Independent Chairman of the Board | ||
| Regina Dugan, Independent Director | ||
| David Illingworth, Independent Director | ||
| Judy Bruner, Independent Director | ||
| Kolleen Kennedy, Executive Vice President, President - Proton Solutions Division and Chief Growth Officer | ||
| J Bruff, Chief Financial Officer, Senior Vice President - Finance | ||
| Christopher Toth, President, Chief Executive Officer, Chief Operating Officer | ||
| Michael Hutchinson, Senior Vice President, Chief Legal Officer, Corporate Secretary | ||
| Anat Ashkenazi, Independent Director | ||
| Phillip Febbo, Chief Medical Officer, Director | ||
| JeanLuc Butel, Independent Director | ||
| Kevin OReilly, Senior Vice President and President Oncology Systems | ||
| Chris Toth, President - Varian Oncology Systems | ||
| Dow Wilson, President, Chief Executive Officer, Director | ||
| Michelle Beau, Independent Director | ||
| Francis Facchini, President Interventional Solutions Business |
Varian Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Varian Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 13.51 | |||
| Return On Asset | 5.92 | |||
| Profit Margin | 8.90 % | |||
| Operating Margin | 16.82 % | |||
| Current Valuation | 15.86 B | |||
| Shares Outstanding | 91.84 M | |||
| Shares Owned By Insiders | 0.29 % | |||
| Shares Owned By Institutions | 86.66 % | |||
| Number Of Shares Shorted | 2.6 M | |||
| Price To Earning | 58.41 X |
Pair Trading with Varian Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Varian Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Varian Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Varian Stock
If you are still planning to invest in Varian Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Varian Medical's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |